$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Payment of Exercise | F | 33.39 | 292 | 9,750 | 24,140 | 24.4 K to 24.1 K (-1.20 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Payment of Exercise | F | 33.39 | 570 | 19,032 | 24,432 | 25 K to 24.4 K (-2.28 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.39 | 734 | 24,508 | 26,740 | 27.5 K to 26.7 K (-2.67 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.39 | 657 | 21,937 | 27,474 | 28.1 K to 27.5 K (-2.34 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 33.39 | 815 | 27,213 | 19,779 | 20.6 K to 19.8 K (-3.96 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 33.39 | 892 | 29,784 | 20,594 | 21.5 K to 20.6 K (-4.15 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.39 | 550 | 18,365 | 31,897 | 32.4 K to 31.9 K (-1.70 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 33.39 | 880 | 29,383 | 32,447 | 33.3 K to 32.4 K (-2.64 %) |
Nov 21 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 39.11 | 10,000 | 391,100 | 33,327 | 43.3 K to 33.3 K (-23.08 %) |
Nov 12 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 39.53 | 3,500 | 138,355 | 21,486 | 25 K to 21.5 K (-14.01 %) |
Nov 18 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 36.22 | 750 | 27,165 | 18,823 | 19.6 K to 18.8 K (-3.83 %) |
Nov 12 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 1,150 | 24,783 | 5,750 | |
Nov 12 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 41.59 | 1,150 | 47,829 | 25,002 | 26.2 K to 25 K (-4.40 %) |
Nov 12 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 1,150 | 24,783 | 26,152 | 25 K to 26.2 K (+4.60 %) |
Oct 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 40.21 | 750 | 30,158 | 19,573 | 20.3 K to 19.6 K (-3.69 %) |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 2,500 | 50,783 | 1,250 | |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 48.70 | 2,500 | 121,750 | 16,537 | 19 K to 16.5 K (-13.13 %) |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 2,500 | 50,783 | 19,037 | 16.5 K to 19 K (+15.12 %) |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 1,150 | 24,783 | 6,900 | |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 48.70 | 1,150 | 56,005 | 30,402 | 31.6 K to 30.4 K (-3.64 %) |
Oct 02 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 1,150 | 24,783 | 31,552 | 30.4 K to 31.6 K (+3.78 %) |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 1,150 | 24,783 | 8,050 | |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 50.42 | 1,150 | 57,983 | 30,253 | 31.4 K to 30.3 K (-3.66 %) |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 1,150 | 24,783 | 31,403 | 30.3 K to 31.4 K (+3.80 %) |
Sep 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 15.02 | 1,000 | 15,020 | 6,000 | |
Sep 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 49.57 | 1,750 | 86,748 | 20,323 | 22.1 K to 20.3 K (-7.93 %) |
Sep 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 15.02 | 1,000 | 15,020 | 22,073 | 21.1 K to 22.1 K (+4.75 %) |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 36.13 | 1,250 | 45,156 | 13,750 | |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 2,500 | 50,783 | 3,750 | |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 50.42 | 3,750 | 189,075 | 16,537 | 20.3 K to 16.5 K (-18.48 %) |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 36.13 | 1,250 | 45,156 | 20,287 | 19 K to 20.3 K (+6.57 %) |
Sep 04 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 2,500 | 50,783 | 19,037 | 16.5 K to 19 K (+15.12 %) |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 15.02 | 500 | 7,510 | 7,000 | |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 500 | 10,157 | 0 | |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 52.83 | 750 | 39,623 | 21,073 | 21.8 K to 21.1 K (-3.44 %) |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 52.83 | 500 | 26,415 | 21,823 | 22.3 K to 21.8 K (-2.24 %) |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 15.02 | 500 | 7,510 | 22,323 | 21.8 K to 22.3 K (+2.29 %) |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 52.83 | 500 | 26,415 | 21,823 | 22.3 K to 21.8 K (-2.24 %) |
Aug 19 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 500 | 10,157 | 22,323 | 21.8 K to 22.3 K (+2.29 %) |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 20.31 | 3,750 | 76,174 | 6,250 | |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 52.27 | 3,750 | 196,013 | 12,787 | 16.5 K to 12.8 K (-22.68 %) |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 20.31 | 3,750 | 76,174 | 16,537 | 12.8 K to 16.5 K (+29.33 %) |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Option Exercise | M | 21.55 | 1,150 | 24,783 | 9,200 | |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Sell | S | 52.27 | 1,150 | 60,111 | 30,088 | 31.2 K to 30.1 K (-3.68 %) |
Aug 05 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Buy | M | 21.55 | 1,150 | 24,783 | 31,238 | 30.1 K to 31.2 K (+3.82 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 15,000 | 357,750 | 112,500 | |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.41 | 300 | 16,023 | 28,131 | 28.4 K to 28.1 K (-1.06 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.40 | 300 | 16,020 | 28,431 | 28.7 K to 28.4 K (-1.04 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.29 | 500 | 26,645 | 28,731 | 29.2 K to 28.7 K (-1.71 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.26 | 900 | 47,934 | 29,231 | 30.1 K to 29.2 K (-2.99 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.20 | 1,100 | 58,520 | 30,131 | 31.2 K to 30.1 K (-3.52 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.24 | 530 | 28,217 | 31,231 | 31.8 K to 31.2 K (-1.67 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.22 | 1,200 | 63,864 | 31,761 | 33 K to 31.8 K (-3.64 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.21 | 600 | 31,926 | 32,961 | 33.6 K to 33 K (-1.79 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.18 | 900 | 47,862 | 33,561 | 34.5 K to 33.6 K (-2.61 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.23 | 285 | 15,171 | 34,461 | 34.7 K to 34.5 K (-0.82 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.25 | 285 | 15,176 | 34,746 | 35 K to 34.7 K (-0.81 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.04 | 300 | 15,912 | 35,031 | 35.3 K to 35 K (-0.85 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.02 | 600 | 31,812 | 35,331 | 35.9 K to 35.3 K (-1.67 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.00 | 700 | 37,100 | 35,931 | 36.6 K to 35.9 K (-1.91 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.75 | 400 | 21,100 | 36,631 | 37 K to 36.6 K (-1.08 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.59 | 500 | 26,295 | 37,031 | 37.5 K to 37 K (-1.33 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.87 | 1,200 | 63,444 | 37,531 | 38.7 K to 37.5 K (-3.10 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.50 | 1,400 | 73,500 | 38,731 | 40.1 K to 38.7 K (-3.49 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.53 | 300 | 15,759 | 40,131 | 40.4 K to 40.1 K (-0.74 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.56 | 900 | 47,304 | 40,431 | 41.3 K to 40.4 K (-2.18 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.62 | 300 | 15,786 | 41,331 | 41.6 K to 41.3 K (-0.72 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.72 | 300 | 15,816 | 41,631 | 41.9 K to 41.6 K (-0.72 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.73 | 500 | 26,365 | 41,931 | 42.4 K to 41.9 K (-1.18 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.67 | 300 | 15,801 | 42,431 | 42.7 K to 42.4 K (-0.70 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.52 | 400 | 21,008 | 42,731 | 43.1 K to 42.7 K (-0.93 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 15,000 | 357,750 | 43,131 | 28.1 K to 43.1 K (+53.32 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 600 | 31,230 | 0 | 600 to 0 (-100.00 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 300 | 15,615 | 600 | 900 to 600 (-33.33 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 2,800 | 145,740 | 900 | 3.7 K to 900 (-75.68 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.07 | 100 | 5,207 | 3,700 | 3.8 K to 3.7 K (-2.63 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.07 | 100 | 5,207 | 3,800 | 3.9 K to 3.8 K (-2.56 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.07 | 100 | 5,207 | 3,900 | 4 K to 3.9 K (-2.50 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.07 | 100 | 5,207 | 4,000 | 4.1 K to 4 K (-2.44 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 600 | 31,230 | 4,100 | 4.7 K to 4.1 K (-12.77 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 100 | 5,205 | 4,700 | 4.8 K to 4.7 K (-2.08 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.07 | 200 | 10,414 | 4,800 | 5 K to 4.8 K (-4.00 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.50 | 200 | 10,500 | 11,500 | 11.7 K to 11.5 K (-1.71 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 300 | 15,615 | 11,700 | 12 K to 11.7 K (-2.50 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 2,200 | 114,510 | 12,000 | 14.2 K to 12 K (-15.49 %) |
Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 52.05 | 300 | 15,615 | 14,200 | 14.5 K to 14.2 K (-2.07 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Option Exercise | M | 30.74 | 50,000 | 1,537,000 | 0 | |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.00 | 23,753 | 1,211,403 | 43,327 | 67.1 K to 43.3 K (-35.41 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.01 | 5,254 | 268,007 | 67,080 | 72.3 K to 67.1 K (-7.26 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.04 | 1,800 | 91,872 | 72,334 | 74.1 K to 72.3 K (-2.43 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.03 | 1,400 | 71,442 | 74,134 | 75.5 K to 74.1 K (-1.85 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.02 | 600 | 30,612 | 75,534 | 76.1 K to 75.5 K (-0.79 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.05 | 1,621 | 82,752 | 76,134 | 77.8 K to 76.1 K (-2.08 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.07 | 800 | 40,856 | 77,755 | 78.6 K to 77.8 K (-1.02 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.10 | 3,272 | 167,199 | 78,555 | 81.8 K to 78.6 K (-4.00 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.12 | 5,200 | 265,824 | 81,827 | 87 K to 81.8 K (-5.98 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.13 | 479 | 24,491 | 87,027 | 87.5 K to 87 K (-0.55 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.11 | 900 | 45,999 | 87,506 | 88.4 K to 87.5 K (-1.02 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.20 | 32 | 1,638 | 88,406 | 88.4 K to 88.4 K (-0.04 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.18 | 1,000 | 51,180 | 88,438 | 89.4 K to 88.4 K (-1.12 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.16 | 1,468 | 75,103 | 89,438 | 90.9 K to 89.4 K (-1.61 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.17 | 200 | 10,234 | 90,906 | 91.1 K to 90.9 K (-0.22 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.22 | 100 | 5,122 | 91,106 | 91.2 K to 91.1 K (-0.11 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.09 | 1,421 | 72,599 | 91,206 | 92.6 K to 91.2 K (-1.53 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.06 | 100 | 5,106 | 92,627 | 92.7 K to 92.6 K (-0.11 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Sell | S | 51.08 | 600 | 30,648 | 92,727 | 93.3 K to 92.7 K (-0.64 %) |
Jul 28 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Buy | M | 30.74 | 50,000 | 1,537,000 | 93,327 | 43.3 K to 93.3 K (+115.40 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 36.13 | 5,000 | 180,625 | 10,000 | |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 50.00 | 5,000 | 250,000 | 16,537 | 21.5 K to 16.5 K (-23.22 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 36.13 | 5,000 | 180,625 | 21,537 | 16.5 K to 21.5 K (+30.24 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Option Exercise | M | 23.83 | 2,000 | 47,660 | 11,500 | |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Sell | S | 50.00 | 2,000 | 100,000 | 8,531 | 10.5 K to 8.5 K (-18.99 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | Sr.VP Bus. Admin. & ... | Buy | M | 23.85 | 2,000 | 47,700 | 10,531 | 8.5 K to 10.5 K (+23.44 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 9,941 | 237,093 | 127,500 | |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.19 | 341 | 17,115 | 28,131 | 28.5 K to 28.1 K (-1.20 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.17 | 1,200 | 60,204 | 28,472 | 29.7 K to 28.5 K (-4.04 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.01 | 1,668 | 83,417 | 29,672 | 31.3 K to 29.7 K (-5.32 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.00 | 5,732 | 286,600 | 31,340 | 37.1 K to 31.3 K (-15.46 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.02 | 300 | 15,006 | 37,072 | 37.4 K to 37.1 K (-0.80 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.05 | 200 | 10,010 | 37,372 | 37.6 K to 37.4 K (-0.53 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.04 | 500 | 25,020 | 37,572 | 38.1 K to 37.6 K (-1.31 %) |
Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 9,941 | 237,093 | 38,072 | 28.1 K to 38.1 K (+35.34 %) |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 1,000 | 20,313 | 500 | |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 45.00 | 750 | 33,750 | 21,823 | 22.6 K to 21.8 K (-3.32 %) |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 45.00 | 1,000 | 45,000 | 22,573 | 23.6 K to 22.6 K (-4.24 %) |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 1,000 | 20,313 | 23,573 | 22.6 K to 23.6 K (+4.43 %) |
Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 59 | 1,407 | 137,441 | |
Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.00 | 59 | 2,950 | 28,131 | 28.2 K to 28.1 K (-0.21 %) |
Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 59 | 1,407 | 28,190 | 28.1 K to 28.2 K (+0.21 %) |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 5,000 | 119,250 | 137,500 | |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 47.50 | 5,000 | 237,500 | 28,131 | 33.1 K to 28.1 K (-15.09 %) |
Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 5,000 | 119,250 | 33,131 | 28.1 K to 33.1 K (+17.77 %) |
Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | SIMON ROBERT L | Exec. VP, Pharm. De ... | Payment of Exercise | F | 44.72 | 388 | 17,351 | 30,088 | 30.5 K to 30.1 K (-1.27 %) |
Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | Sr. V.P. & General ... | Payment of Exercise | F | 44.72 | 473 | 21,153 | 19,589 | 20.1 K to 19.6 K (-2.36 %) |
Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 44.72 | 566 | 25,312 | 28,131 | 28.7 K to 28.1 K (-1.97 %) |
Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | ATIEH MICHAEL G | Exec. VP & CFO | Payment of Exercise | F | 44.72 | 633 | 28,308 | 43,327 | 44 K to 43.3 K (-1.44 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 20.31 | 3,500 | 71,096 | 1,500 | |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 45.00 | 3,500 | 157,500 | 22,573 | 26.1 K to 22.6 K (-13.42 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 20.31 | 3,500 | 71,096 | 26,073 | 22.6 K to 26.1 K (+15.51 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | M | 36.25 | 750 | 27,188 | 2,250 | |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Option Exercise | M | 30.39 | 12,500 | 379,875 | 12,500 | |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.12 | 400 | 18,048 | 14,500 | 14.9 K to 14.5 K (-2.68 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.13 | 1,785 | 80,557 | 14,900 | 16.7 K to 14.9 K (-10.70 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.14 | 1,100 | 49,654 | 16,685 | 17.8 K to 16.7 K (-6.18 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.17 | 500 | 22,585 | 17,785 | 18.3 K to 17.8 K (-2.73 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.15 | 850 | 38,378 | 18,285 | 19.1 K to 18.3 K (-4.44 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.18 | 2,300 | 103,914 | 19,135 | 21.4 K to 19.1 K (-10.73 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.18 | 100 | 4,518 | 21,435 | 21.5 K to 21.4 K (-0.46 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.16 | 315 | 14,225 | 21,535 | 21.9 K to 21.5 K (-1.44 %) |
Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | KLEIN JOSEPH III | Director | Sell | S | 45.09 | 800 | 36,072 | 21,850 | 22.7 K to 21.9 K (-3.53 %) |